These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 14989405)

  • 21. [Early recognition and early treatment of schizophrenia: chance or dilemma?].
    Resch F
    Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):235-44. PubMed ID: 18654955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
    Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
    Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saccadic eye movement task identifies cognitive deficits in children with schizophrenia, but not in unaffected child relatives.
    Ross RG; Heinlein S; Zerbe GO; Radant A
    J Child Psychol Psychiatry; 2005 Dec; 46(12):1354-62. PubMed ID: 16313436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Brain imaging and transition to psychosis].
    McGuire P
    Encephale; 2010 Mar; 36 Suppl 3():S66-70. PubMed ID: 21095395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social functioning in individuals at clinical high risk for psychosis.
    Addington J; Penn D; Woods SW; Addington D; Perkins DO
    Schizophr Res; 2008 Feb; 99(1-3):119-24. PubMed ID: 18023329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia: genes and environment.
    Tsuang M
    Biol Psychiatry; 2000 Feb; 47(3):210-20. PubMed ID: 10682218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurodevelopmental factors associated with schizotypal symptoms among adolescents at risk for schizophrenia.
    Hans SL; Auerbach JG; Nuechterlein KH; Asarnow RF; Asarnow J; Styr B; Marcus J
    Dev Psychopathol; 2009; 21(4):1195-210. PubMed ID: 19825264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
    Lieberman JA; Malaspina D; Jarskog LF
    CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subthreshold symptoms and vulnerability indicators (e.g., eye tracking dysfunction) in schizophrenia.
    Flechtner KM; Steinacher B; Mackert A
    Compr Psychiatry; 2000; 41(2 Suppl 1):86-9. PubMed ID: 10746909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of schizophrenia.
    Häfner H; an der Heiden W
    Can J Psychiatry; 1997 Mar; 42(2):139-51. PubMed ID: 9067063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of neuroimaging studies of young relatives of individuals with schizophrenia: a developmental perspective from schizotaxia to schizophrenia.
    Thermenos HW; Keshavan MS; Juelich RJ; Molokotos E; Whitfield-Gabrieli S; Brent BK; Makris N; Seidman LJ
    Am J Med Genet B Neuropsychiatr Genet; 2013 Oct; 162B(7):604-35. PubMed ID: 24132894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eye movements in spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients.
    Thaker GK; Cassady S; Adami H; Moran M; Ross DE
    Am J Psychiatry; 1996 Mar; 153(3):362-8. PubMed ID: 8610823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus.
    Seidman LJ; Pantelis C; Keshavan MS; Faraone SV; Goldstein JM; Horton NJ; Makris N; Falkai P; Caviness VS; Tsuang MT
    Schizophr Bull; 2003; 29(4):803-30. PubMed ID: 14989416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?
    Diwadkar VA; Montrose DM; Dworakowski D; Sweeney JA; Keshavan MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):230-8. PubMed ID: 16318899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The schizophrenia prodrome revisited: a neurodevelopmental perspective.
    Cornblatt BA; Lencz T; Smith CW; Correll CU; Auther AM; Nakayama E
    Schizophr Bull; 2003; 29(4):633-51. PubMed ID: 14989404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain imaging during the transition from psychosis prodrome to schizophrenia.
    Chung Y; Cannon TD
    J Nerv Ment Dis; 2015 May; 203(5):336-41. PubMed ID: 25900551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.
    Carpenter WT; Bustillo JR; Thaker GK; van Os J; Krueger RF; Green MJ
    Psychol Med; 2009 Dec; 39(12):2025-42. PubMed ID: 19796428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
    Radoeva PD; Fremont W; Antshel KM; Kates WR
    Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.